Sign inGet started

Omega Fund IV, L.P.

Insider CIK 1528382 · PRTK 10% owner · EGLT 10% owner · KZR · TBIO 10% owner · REPL Director, 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
REPL Replimune Group, Inc. S Sale2022-03-162022-03-1638,762$15.55 $602.7K4,673,380SEC↗
REPL Replimune Group, Inc. S Sale2022-03-162022-03-166,238$15.31 $95.5K4,712,142SEC↗
REPL Replimune Group, Inc. S Sale2022-03-152022-03-1645,000$15.64 $703.8K4,718,380SEC↗
REPL Replimune Group, Inc. M Exercise deriv2022-03-142022-03-1616,500— $016,500SEC↗
REPL Replimune Group, Inc. S Sale2022-03-142022-03-1616,500$15.42 $254.4K4,763,380SEC↗
REPL Replimune Group, Inc. M Exercise2022-03-142022-03-1616,500$9.78 $161.4K4,779,880SEC↗
REPL Replimune Group, Inc. S Sale2021-11-222021-11-2310,162$34.70 $352.6K4,763,380SEC↗
REPL Replimune Group, Inc. S Sale2021-11-192021-11-2334,845$34.54 $1.20M4,773,959SEC↗
REPL Replimune Group, Inc. S Sale2021-11-192021-11-23417$34.80 $14.5K4,773,542SEC↗
REPL Replimune Group, Inc. S Sale2021-11-182021-11-182,441$33.50 $81.8K4,808,804SEC↗
REPL Replimune Group, Inc. S Sale2021-11-182021-11-182,441$33.50 $81.8K4,808,804SEC↗
REPL Replimune Group, Inc. S Sale2021-11-162021-11-18153$33.50 $5.1K4,811,245SEC↗
REPL Replimune Group, Inc. S Sale2021-11-162021-11-18153$33.50 $5.1K4,811,245SEC↗
REPL Replimune Group, Inc. S Sale2021-11-152021-11-16782$33.66 $26.3K4,811,398SEC↗
REPL Replimune Group, Inc. S Sale2021-11-122021-11-1623,235$33.66 $782.1K4,812,180SEC↗
REPL Replimune Group, Inc. S Sale2021-11-112021-11-1218,279$33.61 $614.4K4,835,415SEC↗
REPL Replimune Group, Inc. S Sale2021-11-102021-11-1211$33.50 $3694,853,694SEC↗
REPL Replimune Group, Inc. S Sale2021-11-092021-11-107,537$33.73 $254.2K4,853,705SEC↗
REPL Replimune Group, Inc. S Sale2021-11-082021-11-103,817$33.53 $128.0K4,861,242SEC↗
REPL Replimune Group, Inc. S Sale2021-11-052021-11-085,790$33.50 $194.0K4,865,059SEC↗
REPL Replimune Group, Inc. S Sale2021-11-042021-11-0825,225$33.58 $847.1K4,870,849SEC↗
REPL Replimune Group, Inc. S Sale2021-09-232021-09-2712,171$33.58 $408.7K4,896,074SEC↗
REPL Replimune Group, Inc. S Sale2021-09-172021-09-2015,465$33.71 $521.3K4,908,245SEC↗
REPL Replimune Group, Inc. S Sale2021-09-172021-09-2078,998$32.88 $2.60M4,923,710SEC↗
REPL Replimune Group, Inc. S Sale2021-09-162021-09-205,537$32.55 $180.2K5,002,708SEC↗
REPL Replimune Group, Inc. A Award deriv2021-04-012021-04-0516,500— $016,500SEC↗
REPL Replimune Group, Inc. S Sale2021-02-082021-02-115,249$45.00 $236.2K5,141,321SEC↗
REPL Replimune Group, Inc. S Sale2021-01-262021-01-283,393$46.04 $156.2K5,283,682SEC↗
REPL Replimune Group, Inc. S Sale2021-01-262021-01-2826,957$45.34 $1.22M5,287,075SEC↗
REPL Replimune Group, Inc. S Sale2021-01-222021-01-268,090$45.05 $364.5K5,317,301SEC↗
REPL Replimune Group, Inc. S Sale2021-01-222021-01-263,269$45.03 $147.2K5,314,032SEC↗
REPL Replimune Group, Inc. S Sale2021-01-152021-01-191,916$45.19 $86.6K5,325,391SEC↗
REPL Replimune Group, Inc. S Sale2021-01-142021-01-1917,664$45.09 $796.5K5,327,307SEC↗
REPL Replimune Group, Inc. A Award deriv2020-04-012020-04-0316,500— $016,500SEC↗
REPL Replimune Group, Inc. P Buy2019-11-182019-11-20220,000$13.61 $2.99M5,328,939SEC↗
REPL Replimune Group, Inc. A Award deriv2019-04-012019-04-0313,500— $013,500SEC↗
REPL Replimune Group, Inc. C Conversion deriv2018-07-242018-07-2525,000— $00SEC↗
REPL Replimune Group, Inc. C Conversion deriv2018-07-242018-07-25101,896— $00SEC↗
REPL Replimune Group, Inc. C Conversion deriv2018-07-242018-07-25259,366— $00SEC↗
REPL Replimune Group, Inc. C Conversion deriv2018-07-242018-07-25100,000— $00SEC↗
REPL Replimune Group, Inc. C Conversion deriv2018-07-242018-07-25248,672— $0248,672SEC↗
REPL Replimune Group, Inc. P Buy2018-07-242018-07-25266,667$15.00 $4.00M266,667SEC↗
REPL Replimune Group, Inc. C Conversion2018-07-242018-07-251,013,547— $04,854,783SEC↗
REPL Replimune Group, Inc. C Conversion2018-07-242018-07-25994,688— $01,261,355SEC↗
REPL Replimune Group, Inc. C Conversion2018-07-242018-07-252,579,881— $03,841,236SEC↗
REPL Replimune Group, Inc. A Award deriv2018-07-192018-07-2513,500— $013,500SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-032,500,000— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-032,500,000— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-031,676,348— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-031,676,348— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-031,263,484— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-031,263,484— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-03302,173— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-03302,173— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-032,000,103— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-032,000,103— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-035,800,000— $00SEC↗
TBIO Translate Bio, Inc. C Conversion deriv2018-07-022018-07-035,800,000— $00SEC↗
TBIO Translate Bio, Inc. C Conversion2018-07-022018-07-03979,179— $0979,179SEC↗
TBIO Translate Bio, Inc. C Conversion2018-07-022018-07-03979,179— $0979,179SEC↗
TBIO Translate Bio, Inc. C Conversion2018-07-022018-07-031,458,424— $01,458,424SEC↗
TBIO Translate Bio, Inc. C Conversion2018-07-022018-07-031,458,424— $01,458,424SEC↗
KZR Kezar Life Sciences, Inc. C Conversion deriv2018-06-252018-06-25377,783— $00SEC↗
KZR Kezar Life Sciences, Inc. C Conversion deriv2018-06-252018-06-25377,783— $00SEC↗
KZR Kezar Life Sciences, Inc. C Conversion deriv2018-06-252018-06-25315,489— $00SEC↗
KZR Kezar Life Sciences, Inc. C Conversion deriv2018-06-252018-06-25315,489— $00SEC↗
KZR Kezar Life Sciences, Inc. C Conversion2018-06-252018-06-25377,783— $0693,272SEC↗
KZR Kezar Life Sciences, Inc. C Conversion2018-06-252018-06-25377,783— $0693,272SEC↗
KZR Kezar Life Sciences, Inc. C Conversion2018-06-252018-06-25315,489— $0315,489SEC↗
KZR Kezar Life Sciences, Inc. C Conversion2018-06-252018-06-25315,489— $0315,489SEC↗
PRTK Paratek Pharmaceuticals, I P Buy2016-06-272016-06-2976,923$13.00 $1000.0K1,187,365SEC↗
PRTK Paratek Pharmaceuticals, I P Buy2016-06-272016-06-29384,615$13.00 $5.00M779,802SEC↗
EGLT Egalet Corp C Conversion deriv2014-02-112014-02-13251,125— $00SEC↗
EGLT Egalet Corp X Exercise deriv2014-02-112014-02-130— $00SEC↗
EGLT Egalet Corp C Conversion deriv2014-02-112014-02-130— $00SEC↗
EGLT Egalet Corp C Conversion deriv2014-02-112014-02-1360,000— $00SEC↗
EGLT Egalet Corp X Exercise deriv2014-02-112014-02-13112,500— $00SEC↗
EGLT Egalet Corp C Conversion deriv2014-02-112014-02-130— $00SEC↗
EGLT Egalet Corp C Conversion deriv2014-02-112014-02-13438,364— $00SEC↗
EGLT Egalet Corp C Conversion deriv2014-02-112014-02-13523,799— $00SEC↗
EGLT Egalet Corp C Conversion2014-02-112014-02-13213,136$6.00 $1.28M1,538,924SEC↗
EGLT Egalet Corp C Conversion2014-02-112014-02-13171,241$6.00 $1.03M231,241SEC↗
EGLT Egalet Corp X Exercise2014-02-112014-02-1360,000— $060,000SEC↗
EGLT Egalet Corp P Buy2014-02-112014-02-13156,250$12.00 $1.88M2,016,251SEC↗
EGLT Egalet Corp C Conversion2014-02-112014-02-13321,077$6.00 $1.93M1,860,001SEC↗
EGLT Egalet Corp P Buy2014-02-112014-02-1383,333$12.00 $1000.0K314,574SEC↗
EGLT Egalet Corp X Exercise2014-02-112014-02-13112,500— $01,325,788SEC↗
EGLT Egalet Corp C Conversion2014-02-112014-02-13523,799— $01,213,288SEC↗
EGLT Egalet Corp C Conversion2014-02-112014-02-13251,125— $0689,489SEC↗
EGLT Egalet Corp C Conversion2014-02-112014-02-13438,364— $0438,364SEC↗